Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EndoTAG-1 + Gemcitabine in Pancreatic Cancer
NCT00377936Phase 2Completed
- Sponsor
- Medigene AG
- Start
- Sep 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of EndoTAG-1 in pancreatic adenocarcinoma (PDAC), sponsored by Medigene AG. Started Sep 2005; status: completed.
02
Drugs
EndoTAG-1
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00377936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00377936.